Qiang Z, Barnett L, Bingham G, Han O, Walsh A, Conwill M
J Neurol. 2024; 272(1):35.
PMID: 39666128
PMC: 11638302.
DOI: 10.1007/s00415-024-12737-y.
van Dommelen P, van Dijk O, de Wilde J, Verkerk P
Orphanet J Rare Dis. 2024; 19(1):192.
PMID: 38730494
PMC: 11088161.
DOI: 10.1186/s13023-024-03208-8.
Gatto F, Benemei S, Piluso G, Bello L
Front Genet. 2024; 15:1360224.
PMID: 38596212
PMC: 11002111.
DOI: 10.3389/fgene.2024.1360224.
Tinker R, Fisher M, Gimeno A, Gill K, Ivey C, Peterson J
Genet Med. 2024; 26(4):101074.
PMID: 38243783
PMC: 11140588.
DOI: 10.1016/j.gim.2024.101074.
Armstrong N, Apkon S, Berggren K, Braun C, Ciafaloni E, Connolly A
J Neuromuscul Dis. 2024; 11(2):525-533.
PMID: 38189762
PMC: 10977386.
DOI: 10.3233/JND-230180.
Preliminary Results of a Genetic Study of Children with Duchenne Myodystrophy in Aktobe, Kazakhstan.
Umurzakova A, Ayaganov D, Mannapova A, Dzhumasheva B, Dzhaksybayeva A
Arch Razi Inst. 2023; 78(3):949-954.
PMID: 38028863
PMC: 10657926.
DOI: 10.22092/ARI.2022.360050.2534.
Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications.
Mercuri E, Pane M, Cicala G, Brogna C, Ciafaloni E
Front Pediatr. 2023; 11:1276144.
PMID: 38027286
PMC: 10667703.
DOI: 10.3389/fped.2023.1276144.
Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals?.
Gorji A, Ostaszewski P, Urbanska K, Sadkowski T
Biomedicines. 2023; 11(8).
PMID: 37626825
PMC: 10452677.
DOI: 10.3390/biomedicines11082329.
Duchenne muscular dystrophy in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact.
Orso M, Migliore A, Polistena B, Russo E, Gatto F, Monterubbianesi M
PLoS One. 2023; 18(6):e0287774.
PMID: 37368924
PMC: 10298760.
DOI: 10.1371/journal.pone.0287774.
Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis.
Mercuri E, Osorio A, Muntoni F, Buccella F, Desguerre I, Kirschner J
J Neurol. 2023; 270(8):3896-3913.
PMID: 37115359
PMC: 10141820.
DOI: 10.1007/s00415-023-11687-1.
Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy.
Viggiano E, Picillo E, Passamano L, Onore M, Piluso G, Scutifero M
Genes (Basel). 2023; 14(1).
PMID: 36672955
PMC: 9859256.
DOI: 10.3390/genes14010214.
Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany.
Hiebeler M, Thiele S, Reilich P, Bernert G, Walter M
Sci Rep. 2023; 13(1):179.
PMID: 36604563
PMC: 9814243.
DOI: 10.1038/s41598-022-27289-2.
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.
Benito-Lozano J, Lopez-Villalba B, Arias-Merino G, Posada de la Paz M, Alonso-Ferreira V
Orphanet J Rare Dis. 2022; 17(1):418.
PMID: 36397119
PMC: 9670379.
DOI: 10.1186/s13023-022-02530-3.
Language Development in Preschool Duchenne Muscular Dystrophy Boys.
Chieffo D, Moriconi F, Mastrilli L, Lino F, Brogna C, Coratti G
Brain Sci. 2022; 12(9).
PMID: 36138988
PMC: 9497138.
DOI: 10.3390/brainsci12091252.
Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study.
Crossnohere N, Armstrong N, Fischer R, Bridges J
Am J Med Genet C Semin Med Genet. 2022; 190(2):169-177.
PMID: 35943031
PMC: 9804254.
DOI: 10.1002/ajmg.c.31992.
Phenotypic Spectrum of Dystrophinopathy Due to Duchenne Muscular Dystrophy Exon 2 Duplications.
Zambon A, Waldrop M, Alles R, Weiss R, Conroy S, Moore-Clingenpeel M
Neurology. 2021; 98(7):e730-e738.
PMID: 34937785
PMC: 8865888.
DOI: 10.1212/WNL.0000000000013246.
Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy.
Schiava M, Amos R, VanRuiten H, McDermott M, Martens W, Gregory S
Neurology. 2021; 98(4):e390-e401.
PMID: 34857536
PMC: 8793104.
DOI: 10.1212/WNL.0000000000013122.
Diagnostic delay in patients with FKRP-related muscular dystrophy.
Coffey L, Stephan C, Zimmerman M, Decker C, Mathews K
Neuromuscul Disord. 2021; 31(12):1235-1240.
PMID: 34857438
PMC: 8692399.
DOI: 10.1016/j.nmd.2021.08.013.
Fondazione Telethon and Unione Italiana Lotta alla Distrofia Muscolare, a successful partnership for neuromuscular healthcare research of value for patients.
Ambrosini A, Baldessari D, Pozzi S, Battaglia M, Beltrami E, Merico A
Orphanet J Rare Dis. 2021; 16(1):408.
PMID: 34600567
PMC: 8487484.
DOI: 10.1186/s13023-021-02047-1.
Prediagnosis pathway benchmarking audit in patients with Duchenne muscular dystrophy.
Gowda V, Fernandez M, Prasad M, Childs A, Hughes I, Tirupathi S
Arch Dis Child. 2021; 107(2):160-165.
PMID: 34244165
PMC: 8785041.
DOI: 10.1136/archdischild-2020-321451.